Introduction to Abritiga 250mg Tablet
Abritiga 250mg Tablet comprises the active ingredient abiraterone acetate and is employed in adult men for the treatment of prostate cancer that has metastasized. It is typically administered alongside steroid medication to reduce the likelihood of side effects. When Abritiga 250mg Tablet is prescribed for the early stages of this condition, it is used in conjunction with testosterone-lowering treatment. This medication is not intended for use in women or children, and effective contraception is essential throughout the treatment. It contains lactose and sodium, so inform your physician if you have lactose intolerance or are on a salt control diet.
Notify the physician if the patients have liver problems, high blood pressure, heart disorders, low blood potassium, diabetes, allergic conditions, or other diseases. Be sure to inform your physician about all the medicines, including supplements and herbal remedies, you are currently taking before commencing treatment with this medication. The most prevalent side effects of this medication include fluid retention in feet or legs, high blood pressure, and diarrhea. A reduction in red blood cells and diminished sex drive may also occur with the intake of Abritiga 250mg Tablet. It’s important to note that this medicine should not be taken concomitantly with Ra-223, a medication used to treat prostate cancer.
Uses of Abritiga 250mg Tablet
- Treatment of prostate cancer
Therapeutic Effects of Abritiga 250mg Tablet
Abritiga 250mg Tablet functions by inhibiting the production of the hormone testosterone in the body, thereby decelerating the growth of prostate cancer.
Interaction of Abritiga 250mg Tablet with other drugs
Notify your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, as well as herbal products you are currently taking or have taken before undergoing treatment. Some medications may interact with Abritiga 250mg Tablet and lead to undesirable side effects.
More Information about Abritiga 250mg Tablet
- This medicine does not require any particular storage condition.
- Keep out of sight and reach of children.
How to consume Abritiga 250mg Tablet
Abritiga 250mg Tablet should always be taken in accordance with the guidance of your physician or pharmacist. Administer the medication orally, without food. Swallow the tablets whole with water, refraining from breaking them. It is advised to consume food at least 2 hours before taking the medication and to abstain from eating for at least 1 hour after taking the medicine. Women who are pregnant or may become pregnant should avoid direct contact with this medication and use gloves.
Safety Advices for Abritiga 250mg Tablet

Pregnancy
Abritiga 250mg Tablet is not recommended for use during pregnancy. Women who are pregnant or may become pregnant should avoid direct contact with this medication and should use gloves.

Breast Feeding
Abritiga 250mg Tablet is not recommended for use in breastfeeding women. It is advisable to inform your doctor if you are breastfeeding before initiating treatment with this medication.

Lungs
Discuss any lung conditions with your doctor before commencing treatment with Abritiga 250mg Tablet.

Liver
Consult your doctor if you have any liver diseases before using Abritiga 250mg Tablet, as this medication is contraindicated in patients with severe liver disorders.

Alcohol
The safety of using Abritiga 250mg Tablet while consuming alcohol is not known. It is advisable to consult your doctor before taking this medication.

Driving
Abritiga 250mg Tablet is unlikely to impact driving or the operation of machinery.
Side Effects of Abritiga 250mg Tablet
Side effects are undesirable symptoms resulting from medical treatment. While all medications have the potential to cause side effects, not everyone will experience them.
Serious:
- Low blood potassium levels (muscle weakness, muscle twitches, or pounding heartbeat)
Common:
- Fluid in legs or feet
- Low blood potassium
- High blood pressure
- Urinary tract infection
- Diarrhea
- High-fat levels in the blood
- Chest pain
- Irregular heartbeat
- Rapid heart rate
- Bone fracture
- Indigestion
- Blood in urine
- Rash
Word of Advice
Notify the doctor if the patient has any liver problems, blood pressure issues, heart disorders, diabetes, or is taking medication for various medical conditions before initiating treatment with Abritiga 250mg Tablet. Adhere to the prescribed dosage as directed by the doctor. Take this medication orally on an empty stomach, without food, and swallow the tablet whole with water without breaking it. Consume food at least 2 hours before taking the medication, and it is recommended to eat after 1 hour following medication consumption. Regular monitoring of blood pressure, potassium levels, and liver function tests is advised while on this medication.
FAQs
Q 1. How to take an Abritiga 250mg Tablet?
Abritiga 250mg Tablet should be taken according to the doctor’s prescription, preferably on an empty stomach. It is recommended to have a meal at least 2 hours before taking the medication, and the patient is advised to eat after 1 hour following medication consumption.
Q 2. Can Abritiga 250mg Tablet cure prostate cancer?
Abritiga 250mg Tablet is not a cure for prostate cancer; rather, it is employed to treat prostate cancer that has metastasized to other parts of the body. Typically, it is administered alongside steroid medication to minimize the risk of side effects. This medication is prescribed in the early stages of the disorder and is combined with testosterone-lowering treatment.
Q 3. Can Abritiga 250mg Tablet worsen liver diseases?
Abritiga 250mg Tablet is not advisable for patients with severe liver conditions, as it may exacerbate the situation. It is essential to inform the doctor if the patient has any pre-existing liver disorders before initiating treatment with this medication.
Q 4. How do Abritiga 250mg Tablet work?
Abritiga 250mg Tablet is an anticancer medication that operates by impeding the production of androgens, thus inhibiting an enzyme responsible for androgen production.
Q 5. Is Abritiga 250mg Tablet a chemotherapy drug?
No, Abritiga 250mg Tablet is not a chemotherapy drug; instead, it is a hormonal treatment employed to address prostate cancer. Its mechanism involves preventing the production of testosterone, thereby diminishing the growth of prostate cancer.
Q 6. What are the side effects of Abritiga 250mg Tablet?
The typical side effects of Abritiga 250mg Tablet include fluid retention in the legs, low blood potassium levels, high blood pressure, urinary tract infection, irregular heartbeat, diarrhea, rashes, and indigestion.
Fact Box of Abritiga 250mg Tablet
Molecule name: Abiraterone acetate
Pharmacological class:
Androstene derivatives
Therapeutic class: Antineoplastics
Indications:
1. Treatment of prostate cancer
1. Treatment of prostate cancer
References
- Centocor Ortho Biotech Inc, US Food and drug administration, [ Revised date: APR 2011] [ Accessed date: 26 MAY 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202379lbl.pdf
- Janssen- Cilag International NV, Electronics Medicine Compendium (emc), [Revised date: SEP 2021] [ Accessed date: 26 MAY 2022] https://www.medicines.org.uk/emc/files/pil.2381.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Natural products in cancer chemotherapy: hormones and related agents, 12th edition, 2011, 1707 – 1709.
Reviews
There are no reviews yet.